Chemical modification of ansamitocins. II. Synthesis of 3-epimaytansionoids via 3-maytansinones

DOI: 10.1248/cpb.32.2773

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 2565 - 2570 (1984)

Update date:2022-09-26

Topics:

Authors:

Akimoto Akimoto

Kawai Kawai

Hashimoto

Nomura Nomura

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.32.2773

Full text of DOI:10.1248/cpb.32.2773

NII-Electronic Library Service

Products guided by the article

Product name:3-epimaytansinol 3-phenylacetate

Cas No:72887-70-8

R&D Labs maybe for 72887-70-8

Angel Yeast Co., Ltd.

Contact:+86-717-6370352

Address:168 Chengdong Avenue, Yichang, Hubei 443003, P. R.China
Shanggao Ruiya Fine Chemicals Co., Ltd

Contact:+86-795-2592103

Address:Xingguang Nanlu,Shanggao County Industry Park
Shanghai PotentPharm Science and Technology Co.,Ltd

Contact:86-021-51969655

Address:Unit B, Building 18, No.300, Chuantu Rd,Pudong District, Shanghai 201202, China
ANTAI BIO-TECH CO LTD

website:http://www.antaibio.com

Contact:0086-21-65663057

Address:Room 2108, Building 2，No. 489 Zhengli Road，200433
Jinan Hongfangde Pharmatech Co.,Ltd

Contact:86-531-88870908

Address:F Bldg. West Unit North Area of Univ. Tech. Garden Xinyu Rd. Jinan New & High Tech Industry Development Zone Shandong, China

Relevant to this article

DABCO-mediated decarboxylative cyclization of isatoic anhydride with aroyl/heteroaroyl/alkoylacetonitriles under microwave conditions: Strategy for the synthesis of substituted 4-quinolones

Doi:10.1016/j.tetlet.2021.153187
(2021)
Site- And enantiodifferentiating C(sp³)-H oxidation enables asymmetric access to structurally and stereochemically diverse saturated cyclic ethers

Doi:10.1021/jacs.0c09636
(2020)
Doi:10.1021/jo01017a020
(1965)
ACID-CATALYSED MONOACETYLATION OF TWO 3-DEOXYHEXITOLS

Doi:10.1016/0008-6215(80)90004-X
(1980)
Development of a Strategy for Convergent Total Synthesis of the Aureolic Acid Antitumor Antibiotics

Doi:10.1021/jo00142a009
(1982)
Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: Discovery of deleobuvir (BI 207127)

Doi:10.1021/jm4011862
(2014)

Article Doi